Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Polo-like kinase 1
(
PLK1
) is an evolutionarily conserved serine/threonine kinase essential for cell mitosis. As a master cell cycle regulator, p21/Waf1 plays a critical role in cell cycle progression. Nitric oxide (NO.) has been shown to down-regulate
PLK1
and up-regulate p21/Waf1 independent of cGMP. Here, the respective roles of p38 MAPK and p21/Waf1 in NO.-mediated
PLK1
repression were investigated using differentiated U937 cells that lack soluble
guanylate cyclase
. NO. was shown to down-regulate both
PLK1
mRNA and protein. Nuclear run-on assays and mRNA stability studies demonstrated that the effect of NO. on
PLK1
expression was associated with decreased transcription without changes in transcript stability. SB202190, a p38 MAPK inhibitor, prevented transcriptional repression of
PLK1
by NO.. Transfection with dominant-negative p38 MAPK mutant eliminated the NO. effect on both p21/Waf1 and
PLK1
gene expression. Knockdown of p21/Waf1 with siRNA also substantially reduced the regulatory effect of NO. on
PLK1
. Reporter gene experiments showed that NO. decreased activity of the
PLK1
proximal promoter, an effect that was blocked by p38 MAPK inhibitor. Deletion or mutation of the CDE/CHR promoter site, an element regulated by p21/Waf1, increased base-line promoter activity and abolished NO. repression of the
PLK1
promoter. Likewise, electrophoretic mobility shift assays with CDE/CHR probe revealed a NO.-mediated change in protein-probe complex formation. Competition with various unlabeled CDE/CHR mutant sequences showed that NO. increased nuclear protein binding to intact CHR. These results demonstrate that a NO.-p38 MAPK-p21/Waf1 signal transduction pathway represses
PLK1
through a canonical CDE/CHR promoter element.
...
PMID:Nitric oxide down-regulates polo-like kinase 1 through a proximal promoter cell cycle gene homology region. 1712 39